Jiwei Huang
9PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 25, 2025
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial Carcinoma.Jiwei Huang, Xingyun Cai, Cheoklong Ng
|Sep 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study.Ruopeng Su, Tingxuan Huang, Liangyou Gu
|Jun 11, 2024
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial.Jiwei Huang, Yueming Wang, Fan Xu
|Mar 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study.Ruopeng Su, Zeyu Chen, Daoping Hong
|Jun 17, 2022
Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy.Yueming Wang, Jiwei Huang, Cuijian Zhang
Pageof 2